EGFR and colorectal carcinoma: Nevertheless, the absence of a standardised scoring system, variations in antibody usage, differences in patient demographics, and, as previously highlighted, the small sample size in certain studies contribute to the observed variability in EGFR expression patterns and the proportion of EGFR-positive cases in CRC patients, as summarised in Table 4.